anti-GRAK antibody product blog
Tags: Antibody; Polyclonal Antibody; GRAK; anti-GRAK antibody;
The GRAK n/a (Catalog #MBS839170) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s GRAK can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA (EIA).WB: 1:500-1:1000
IHC: 1:50-1:100
IF: 1:100-1:500
ELISA: 1:20000. Researchers should empirically determine the suitability of the GRAK n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the GRAK antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue using GRAK antibody.)
Immunofluorescence (IF) (Immunofluorescence analysis of NIH/3T3 cells, using GRAK antibody.)
Western Blot (WB) (Western blot analysis of extracts from Jurkat cells, using GRAK antibody.)
Rabbit polyclonal GRAK antibody.
Biological Significance: GRAK is a member of a group of related serine proteases from the cytoplasmic granules of cytotoxic lymphocytes. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. Cross-Reactivity: Mouse, Rat
Immunogen: GRAK antibody was raised in Rabbit using synthesized peptide derived from internal of human GRAK as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing GRAK are readily searchable from our website. Different antibodies against the same target such as GRAK may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.